Kelly R Bijanki1,2,3, Sanne J H van Rooij3, Timothy D Ely3, Jennifer S Stevens3, Cory S Inman2, Rebecca E Fasano4, Sierra E Carter3, Sterling J Winters3, Justin R Baman3, Daniel L Drane4,5, Tanja Jovanovic3,6, Jon T Willie2,4. 1. Department of Neurosurgery, Baylor College of Medicine, Houston, Texas. 2. Department of Neurosurgery, Emory University School of Medicine, Atlanta, Georgia. 3. Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia. 4. Department of Neurology, Emory University School of Medicine, Atlanta, Georgia. 5. Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia. 6. Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, Detroit, Michigan.
Abstract
BACKGROUND: Post-traumatic stress disorder is a severe psychobiological disorder associated with hyperactivity of the amygdala, particularly on the right side. Highly selective laser ablation of the amygdalohippocampal complex is an effective neurosurgical treatment for medically refractory medial temporal lobe epilepsy that minimizes neurocognitive deficits relative to traditional open surgery. OBJECTIVE: To examine the impact of amygdalohippocampotomy upon symptoms and biomarkers of post-traumatic stress disorder. METHODS: Two patients with well-documented chronic post-traumatic stress disorder who subsequently developed late-onset epilepsy underwent unilateral laser amygdalohippocampotomy. Prospective clinical and neuropsychological measurements were collected in patient 1. Additional prospective measurements of symptoms and biomarkers were collected pre- and post-surgery in patient 2. RESULTS: After laser ablation targeting the nondominant (right) amygdala, both patients experienced not only reduced seizures, but also profoundly abated post-traumatic stress symptoms. Prospective evaluation of biomarkers in patient 2 showed robust improvements in hyperarousal symptoms, fear potentiation of the startle reflex, brain functional magnetic resonance imaging responses to fear-inducing stimuli, and emotional declarative memory. CONCLUSION: These observations support the emerging hypothesis that the right amygdala particularly perpetuates the signs and symptoms of post-traumatic stress disorder and suggests that focal unilateral amydalohippocampotomy can provide therapeutic benefit.
BACKGROUND: Post-traumatic stress disorder is a severe psychobiological disorder associated with hyperactivity of the amygdala, particularly on the right side. Highly selective laser ablation of the amygdalohippocampal complex is an effective neurosurgical treatment for medically refractory medial temporal lobe epilepsy that minimizes neurocognitive deficits relative to traditional open surgery. OBJECTIVE: To examine the impact of amygdalohippocampotomy upon symptoms and biomarkers of post-traumatic stress disorder. METHODS: Two patients with well-documented chronic post-traumatic stress disorder who subsequently developed late-onset epilepsy underwent unilateral laser amygdalohippocampotomy. Prospective clinical and neuropsychological measurements were collected in patient 1. Additional prospective measurements of symptoms and biomarkers were collected pre- and post-surgery in patient 2. RESULTS: After laser ablation targeting the nondominant (right) amygdala, both patients experienced not only reduced seizures, but also profoundly abated post-traumatic stress symptoms. Prospective evaluation of biomarkers in patient 2 showed robust improvements in hyperarousal symptoms, fear potentiation of the startle reflex, brain functional magnetic resonance imaging responses to fear-inducing stimuli, and emotional declarative memory. CONCLUSION: These observations support the emerging hypothesis that the right amygdala particularly perpetuates the signs and symptoms of post-traumatic stress disorder and suggests that focal unilateral amydalohippocampotomy can provide therapeutic benefit.
Authors: Robert E Gross; Matthew A Stern; Jon T Willie; Rebecca E Fasano; Amit M Saindane; Bruno P Soares; Nigel P Pedersen; Daniel L Drane Journal: Ann Neurol Date: 2018-03-03 Impact factor: 10.422
Authors: Michael J Roy; Jennifer Francis; Joshua Friedlander; Lisa Banks-Williams; Raymond G Lande; Patricia Taylor; James Blair; Jennifer McLellan; Wendy Law; Vanita Tarpley; Ivy Patt; Henry Yu; Alan Mallinger; Joann Difede; Albert Rizzo; Barbara Rothbaum Journal: Ann N Y Acad Sci Date: 2010-10 Impact factor: 5.691
Authors: Tanja Jovanovic; Seth D Norrholm; Jennifer E Fennell; Megan Keyes; Ana M Fiallos; Karyn M Myers; Michael Davis; Erica J Duncan Journal: Psychiatry Res Date: 2009-04-05 Impact factor: 3.222
Authors: Candice M Monson; Jaimie L Gradus; Yinong Young-Xu; Paula P Schnurr; Jennifer L Price; Jeremiah A Schumm Journal: Psychol Assess Date: 2008-06
Authors: Anthony Steven Dick; Jonathan S Comer; Karina Silva; Raul Gonzalez; Matthew T Sutherland; Angela R Laird; Wesley K Thompson; Susan F Tapert; Lindsay M Squeglia; Kevin M Gray; Sara Jo Nixon; Linda B Cottler; Annette M La Greca; Robin H Gurwitch Journal: Nat Hum Behav Date: 2021-11-15
Authors: Valerie J Sydnor; Matthew Cieslak; Romain Duprat; Joseph Deluisi; Matthew W Flounders; Hannah Long; Morgan Scully; Nicholas L Balderston; Yvette I Sheline; Dani S Bassett; Theodore D Satterthwaite; Desmond J Oathes Journal: Sci Adv Date: 2022-06-22 Impact factor: 14.957
Authors: Audreyana Jagger-Rickels; David Rothlein; Anna Stumps; Travis Clark Evans; John Bernstein; William Milberg; Regina McGlinchey; Joseph DeGutis; Michael Esterman Journal: Transl Psychiatry Date: 2022-06-27 Impact factor: 7.989